Sponsored by:

Molecular Imaging: Page 467

Siemens launches biomarker research facility
By AuntMinnie.com staff writers
Siemens Medical Solutions has opened a new research facility dedicated to the development of molecular imaging biomarkers.
February 7, 2007
Molecular Insight prices IPO
By AuntMinnie.com staff writers
Molecular Insight Pharmaceuticals has priced the initial public offering (IPO) of 5 million shares of its common stock at $14 per share.
February 1, 2007
DraxImage to bring generic sestamibi to market
By AuntMinnie.com staff writers
Canadian radiopharmaceutical firm DraxImage has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration for its generic kit for the preparation of technetium-99m (Tc-99m) sestamibi.
February 1, 2007
Study: PET accurate for newborns' pancreatic defects
By AuntMinnie.com staff writers
Positron emission tomography (PET) is extremely accurate in diagnosing a type of congenital hyperinsulinism (HI), a rare but severe imbalance of insulin levels in newborns.
January 29, 2007
RAE Systems introduces two new dosimeters
By AuntMinnie.com staff writers
RAE Systems of San Jose, CA, has introduced the DoseRAE and DoseRAE-P Geiger-Mueller tube-based, electronic gamma radiation dosimeters.
January 29, 2007
Advanced Medical Isotopes licenses actinium patent
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotopes of Kennewick, WA, reported that it has licensed a U.S. patent for preparing actinium-225.
January 25, 2007
EBRT/brachytherapy prostate cancer combo shows long-term effectiveness
By Jonathan S. Batchelor
The pairing of external-beam radiation therapy (EBRT) followed by brachytherapy has shown strong results in long-term relapse-free survival rates in prostate cancer patients, according to researchers of a new study. They found that low- and intermediate-risk patients experienced high disease-free survival rates with this treatment.
January 24, 2007
PET added to lymphoma assessment guidelines
By AuntMinnie.com staff writers
New guidelines developed by the International Harmonization Project (IHP) for treatment response assessment of non-Hodgkin's lymphoma aim to standardize the parameters used in clinical trials for lymphoma and incorporate new technologies. The revised guidelines also cover all lymphomas.
January 22, 2007
Study: PET posts double-digit gains in Western Europe
By AuntMinnie.com staff writers
A study by healthcare consultants Medical Options of London estimated that 491,000 patient studies will be performed using PET in Western Europe in 2006.
January 21, 2007
Bayer Schering to develop PET brain imaging agents
By AuntMinnie.com staff writers
Berlin-based Bayer Schering Pharma (formerly Schering) has signed a license and option agreement with two Japanese companies and the National Institute of Radiological Sciences (NIRS) in Japan to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.
January 18, 2007
IBA expands production capacity
By AuntMinnie.com staff writers
Nuclear medicine products firm Ion Beam Applications (IBA) has launched an expansion program to meet the demand for its proton therapy systems.
January 18, 2007
New tracer shows promise for PET/CT prostate imaging
By Jonathan S. Batchelor
One in six men in the U.S. will get prostate cancer during his lifetime, according to recent data. Unfortunately, conventional imaging techniques are limited for detecting, staging, and restaging this carcinoma. But a study by scientists at Emory University in Atlanta and researchers in Japan finds that a new radiotracer shows promse in evaluating and staging prostate cancer.
January 17, 2007
2007 01 17 17 19 14 706
Previous Page
Page 467 of 611
Next Page